Homeostatic plasticity is characterized by compensatory changes in synaptic strength and intrinsic membrane properties in response to chronic changes in neuronal activity. Neonatal seizures are a naturally occurring source of neuronal overactivation and can lead to long-term epilepsy and cognitive deficits. Using a rodent model of hypoxiainduced neonatal seizures that results in a persistent increase in AMPA receptor (AMPAR) function in hippocampal CA1 pyramidal neurons, we aimed to determine whether there was any evidence of an opposing endogenous homeostatic antiepileptic response. Given that this model results in long-term epilepsy, we also examined mechanisms whereby this homeostasis fails. Whole-cell patch-clamp recordings from neurons in slices removed at intervals following seizure onset revealed an initial up-regulation of AMPAR function that was followed by a transient dynamic attenuation of this enhancement by 48-72 h, although AMPAR function was still increased compared with nonseizure control baseline. This secondary down-regulation of enhanced AMPAR function was coincident with a marked transient increase in expression and function of the Polo-like kinase 2 (PLK2), which has previously been implicated in homeostatic down-regulation of neuronal excitability in cell/slice culture models. The effects were transient and at 1 wk AMPAR function once again became up-regulated, simultaneous with a decrease in PLK2 expression and function. This negative regulation was mediated by subacute postseizure increases in mammalian target of rapamycin (mTOR). Application of the mTOR inhibitor rapamycin prevented post-hypoxic seizure impairment of homeostasis, suggesting that homeostatic plasticity mechanisms may be potentially modifiable therapeutic targets in epileptogenesis.pilepsy is one of the most prevalent neurological disorders, affecting ∼1-2% of the United States population (1). The neonatal period is one of the highest incidence periods for seizures across the lifespan, with hypoxic encephalopathy being the most common cause (2, 3). Neonatal seizures are often refractory to conventional antiepileptic drugs and can result in chronic laterlife epilepsy and long-term behavioral and cognitive deficits (4, 5).Using an established neonatal hypoxic seizure (HS) model in rats, we previously showed neonatal HS results in both acute and long-term enhancement in hippocampal and cortical excitability and later-life epilepsy (6-8). We have demonstrated a critical role for seizure-induced early posttranslational modifications of the AMPA receptors (AMPAR) to enhance synaptic excitability (3,6,7,9), and a dependence upon activation of the mammalian target of rapamycin (mTOR) pathway (9).Neonatal seizure-induced increases in AMPAR function involve mechanisms of receptor trafficking implicated in Hebbian synaptic plasticity (6, 10). Although Hebbian synaptic plasticity is robust in the developing brain at baseline and after seizures, relatively few studies have focused on the status of homeostatic plasticity in the developi...